A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Cresto

tablet, rosuvastatin 20mg

DRUG

Olmetec

tablet, olmesartan medoxomil(CS-866) 40mg

DRUG

DWJ1276

tablet, Rosuvastatin 20mg and olmesartan medoxomil 40mg

Trial Locations (1)

Unknown

Yonsei University Health System (Yuhs), Seoul

All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY